Novo Nordisk A/SNVONYSE
Loading
Income Quality Over TimeStable
Percentile Rank43
3Y CAGR-6.5%
5Y CAGR-1.2%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-6.5%/yr
vs +5.3%/yr prior
5Y CAGR
-1.2%/yr
Recent deceleration
Acceleration
-11.8pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive declineStable
PeriodValueYoY Change
20251.16-2.9%
20241.20-8.0%
20231.30-8.4%
20221.42+23.4%
20211.15-6.6%
20201.23+2.7%
20191.20+4.0%
20181.16+7.0%
20171.08-15.2%
20161.27-